Post-therapy paradoxical response in immunocompetent patients with lymph node tuberculosis

Journal of Infection

Volumn 61, Issue 5, 2010, Pages 430-434

  Park, Ki Ho ^a,b   Cho, Oh Hyun ^a,b   Chong, Young Pil ^a,b   Lee, Sang Oh ^a,b   Choi, Sang Ho ^a,b   Jeong, Jin Young ^a,b   Kim, Mi Na ^a   Kim, Yang Soo ^a,b   Woo, Jun Hee ^a,b   Kim, Sung Han ^a,b  

^a University of Ulsan College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

Author keywords

Lymphadenitis; Paradoxical response; Scrofula; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ASPIRATION BIOPSY; BACTERIUM CULTURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; LETTER; LUNG TUBERCULOSIS; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PARADOXICAL DRUG REACTION; PATIENT MONITORING; TREATMENT DURATION; TUBERCULOUS LYMPHADENITIS;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; IMMUNOCOMPETENCE; LYMPH NODES; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; RECURRENCE; REPUBLIC OF KOREA; RISK FACTORS; TUBERCULOSIS, LYMPH NODE; YOUNG ADULT;

EID: 78149358575     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.08.011     Document Type: Letter

References (12)

1. Cho O.H., Park K.H., Kim T., Song E.H., Jang E.Y., Lee E.J., et al. Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis. J Infect 2009, 59:56-61.
2. Hawkey C.R., Yap T., Pereira J., Moore D.A., Davidson R.N., Pasvol G., et al. Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis 2005, 40:1368-1371.
3. Polesky A., Grove W., Bhatia G. Peripheral tuberculous lymphadenitis: epidemiology, diagnosis, treatment, and outcome. Medicine (Baltimore) 2005, 84:350-362.
4. Kim S.H., Choi S.J., Kim H.B., Kim N.J., Oh M.D., Choe K.W. Diagnostic usefulness of a T-cell based assay for extrapulmonary tuberculosis. Arch Intern Med 2007, 167:2255-2259.
5. Liebeschuetz S., Bamber S., Ewer K., Deeks J., Pathan A.A., Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004, 364:2196-2203.
6. Liao C.H., Chou C.H., Lai C.C., Huang Y.T., Tan C.K., Hsu H.L., et al. Diagnostic performance of an enzyme-linked immunospot assay for interferon-gamma in extrapulmonary tuberculosis varies between different sites of disease. J Infect 2009, 59:402-408.
7. Blumberg H.M., Burman W.J., Chaisson R.E., Daley C.L., Etkind S.C., Friedman L.N., et al. American Thoracic Society/Centers for disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003, 167:603-662.
8. Cheng V.C., Yam W.C., Woo P.C., Lau S.K., Hung I.F., Wong S.P., et al. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis 2003, 22:597-602.
9. Short course chemotherapy for tuberculosis of lymph nodes: a controlled trial. British Thoracic Society Research Committee. Br Med J (Clin Res Ed) 1985, 290:1106-1108.
10. Campbell I.A., Dyson A.J. Lymph node tuberculosis: a comparison of treatments 18 months after completion of chemotherapy. Tubercle 1979, 60:95-98.
11. Campbell I.A. The treatment of superficial tuberculous lymphadenitis. Tubercle 1990, 71:1-3.
12. Campbell I.A., Ormerod L.P., Friend J.A., Jenkins P.A., Prescott R.J. Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results. Respir Med 1993, 87:621-623.